Territory License Agreement between Molecular Insight Pharmaceuticals, Inc and BIOMEDICA Life Sciences, S.A.Territory License Agreement • November 9th, 2009 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 9th, 2009 Company IndustryThis territory license agreement (“Agreement”), dated this 1st day of September, 2009 (the “Effective Date”) is entered into by and between Molecular Insight Pharmaceuticals, Inc. (referred to herein as “MIP”), a corporation organized and existing under the laws of The Commonwealth of Massachusetts and having its principal office at 160 Second Street, Cambridge, MA 02142 USA, and BIOMEDICA Life Sciences S.A., a corporation organized and existing under the laws of Greece, with offices at 4 Papanikoli Str., 15232 Halandri, Athens, Greece (referred to herein as “BIOMEDICA”), with Greek Tax ID of 094413470, from the tax office of FAEE Athens; each a “Party” and collectively the “Parties” hereto.